FDA authorizes marketing of first blood test to aid in the evaluation of concussion in adults – FDA.gov

0
7

PR Newswire

FDA authorizes marketing of first blood test to aid in the evaluation of concussion in adults
FDA.gov
The U.S. Food and Drug Administration today permitted marketing of the first blood test to evaluate mild traumatic brain injury (mTBI), commonly referred to as concussion, in adults. The FDA reviewed and authorized for marketing the Banyan Brain Trauma
FDA Allows Marketing of Blood Test for Concussions360Dx

all 7 news articles »

LEAVE A REPLY